BG
DEAD

Serial Number

90524586

Owner

BostonGene Corporation

Attorney

Christina M. Licursi

Filing Date

Feb 11, 2021

Add to watchlist:

No watchlists yet
View on USPTO

BG Trademark

Serial Number: 90524586

BG is a trademark filed by BostonGene Corporation on February 11, 2021. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

BostonGene Corporation (7 trademarks)

Waltham, MA 02453

Entity Type: 03

Trademark Details

Filing Date

February 11, 2021

Registration Date

Not Registered

Goods & Services

Genetic testing for medical purposes, specifically, genomic, epigenomic, proteomic, transcriptomic, and molecular medical testing for cancer and other diagnostic or treatment purposes; providing medical information, namely, providing collected and analyzed medical information in the field of genetics, epigenetics, and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing medical information, specifically, providing collected and analyzed medical information in the field of genomics, epigenomics, proteomics, transcriptomics for diagnostic and treatment purposes; providing medical data and information to healthcare professionals; providing online computer databases of genomic sequences for health care and medical purposes, namely, for tracking, matching, searching, testing, aggregating, researching, evaluating health status, and diagnosing diseases and gene mutations; providing an online Internet website portal featuring medical information, namely, medical, genetic, epigenetic, genomic, proteomic, and transcriptomic information and data in the field of cancer for diagnostic and treatment purposes; providing an online Internet website portal featuring medical information, namely, medical, genetic, epigenetic, genomic, proteomic, and transcriptomic information and data for scientific, laboratory, and medical research and development purposes

Providing online, non-downloadable software for genetic and epigenetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; providing online computer databases featuring scientific research information in the field of genomic sequences for use in scientific research, namely, for tracking, matching, searching, testing, aggregating, researching, and evaluating health status, and diagnosing diseases and gene mutations; software as a service (SAAS) services featuring software for patient treatment protocols and for recommending treatments to patients; providing an online internet website portal featuring medical, genetic, epigenetic, genomic, epigenomic, proteomic, and transcriptomic research information and data in the field of cancer for diagnostic and treatment purposes; providing an online internet website portal featuring medical, genetic, epigenetic, genomic, epigenomic, proteomic, and transcriptomic research information and data for scientific, laboratory, and medical research and development purposes; medical research services; biomedical research services; structural and functional analysis of genomes; scientific research in the field of genomics and epigenomics; medical laboratory services being medical research, in the fields of diagnostics and development of tests for clinical diagnosis and the detection of medical conditions and disorders; providing temporary use of online, non-downloadable software used for the sequencing and analyses of genomic, epigenomic, proteomic, and transcriptomic data; providing temporary use of online, non-downloadable software used to integrate and create data models; software as a service (SAAS) services featuring software for analyzing and visualizing genomic, epigenomic, proteomic, and transcriptomic data, and evaluating health status and diagnosing diseases, disorders, and syndromes; software as a service (SAAS) services featuring software for data management, for electronic storage of data in the field of clinical trials and electronic health records; providing online, non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, epigenetics, genomics, proteomics, transcriptomics, and biochemistry; providing online, nondownloadable software for use in clinical trial data management and for management of electronic health records; providing online, non-downloadable software for displaying, recording, and analyzing medical data and medical images

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jun 1, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 1, 2024 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 21, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 21, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 21, 2024 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 22, 2023 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 13, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 14, 2022 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 14, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 14, 2022 GNSL
SUSPENSION LETTER WRITTEN
Apr 14, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 13, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 13, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 13, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 15, 2021 GNRN
NON-FINAL ACTION E-MAILED
Oct 15, 2021 GNRT
NON-FINAL ACTION WRITTEN
Oct 15, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 8, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 15, 2021 NWOS
NEW APPLICATION ENTERED
Feb 15, 2021 NWAP